Table II.
Correlation between WWOX expression and clinicopathological parameters in epithelial ovarian cancer.
| WWOX expression | ||||||
|---|---|---|---|---|---|---|
| Clinicopathological parameters | Total number of cases (n) | Negative | Positive | Positive rate (%) | χ2 value | P-value |
| Age (years) | ||||||
| <53 | 154 | 95 | 59 | 38.3 | 0.056 | 0.813 |
| ≥53 | 146 | 92 | 54 | 37.0 | ||
| Pathological type | ||||||
| Serous carcinoma | 168 | 104 | 64 | 38.1 | 0.194 | 0.978 |
| Mucinous carcinoma | 63 | 39 | 24 | 38.1 | ||
| Endometrial carcinoma | 54 | 35 | 19 | 35.2 | ||
| Clear cell carcinoma | 15 | 9 | 6 | 40.0 | ||
| FIGO staging | ||||||
| I–II | 143 | 75 | 68 | 47.6 | 11.374 | 0.001 |
| III–IV | 157 | 112 | 45 | 28.7 | ||
| Pathological staging | ||||||
| G1+G2 | 124 | 59 | 65 | 52.4 | 19.593 | <0.001 |
| G3 | 176 | 128 | 48 | 27.3 | ||
| Lymph node metastasis | ||||||
| Yes | 186 | 134 | 52 | 28.0 | 19.654 | <0.001 |
| No | 114 | 53 | 61 | 53.5 | ||
WWOX, WW domain-containing oxidoreductase.